Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Enrolling by invitation

A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT07657052

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: TianJin Medical University General Hospital Tianjin, Jinan, China

View Trial Details

Enrolling by invitation

Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

NCT07651176

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Enrolling by invitation

Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

NCT07651163

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Enrolling by invitation

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

NCT06831734

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations: Chiba university hospital_Pediatrics Chiba, Japan

National Hospital Organization Awara Hospital_Hematology and Oncology Fukui, Japan

Hoshi General Hospital_Pediatrics Fukushima, Japan

Hyogo Prefectural Amagasaki General Medical Center_Haematology Hyōgo, Japan

View all 23 locations

View Trial Details

Enrolling by invitation

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

NCT06285071

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations: Novo Nordisk Investigational Site Toshima City, Tokyo, Japan

Mutsu general hospital_Pediatrics Aomori, Japan

Kyushu university hospital_Pediatrics Fukuoka, Japan

Sapporo Tokushukai Hospital_Pediatrics Hokkaido, Japan

View Trial Details

Enrolling by invitation

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

NCT03745924

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: AKH - Klin. Abt. f. Haematologie u. Haemostaseologie Vienna, Austria

Cliniques universitaires Saint-Luc - Service Hématologie Brussels, Belgium

UZ Antwerpen - UZA - Kinderhemato-Oncologie Edegem, Belgium

UZ Leuven - Hart en Vaatziekten Leuven, Belgium

View all 30 locations

View Trial Details

Enrolling by invitation

CS-101 in Patients With β-thalassemia

NCT06328764

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Enrolling by invitation

Allergy Delabeling in Antibiotic Stewardship - Evaluations

NCT06967467

Conditions: Beta Lactam Allergy in Patients With a Hematologic Malignancy, Hematologic Diseases, Hematologic Neoplasms, +3 more
Locations: Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Enrolling by invitation

Stepped-Care Support for Children With Leukaemia

NCT07587411

Conditions: Childhood Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Hayatabad Medical Complex Peshawar, Khyber Pukhtoon Khwa, Pakistan

View Trial Details

Enrolling by invitation

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NCT05041309

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +3 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

City of Hope Duarte, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

View all 90 locations

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions